LeMaitre Vascular Inc
NASDAQ:LMAT
LeMaitre Vascular Inc
NASDAQ:LMAT
Price:
75 USD
-1.19%
Market Closed
Updated:
May 9, 2024
P/E
Price to Earnings
Price to Earnings
49.3
Current
44
Median
23.4
Industry
Higher
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=49.3
Market Cap
/
1.7B
Net Income
34m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
LeMaitre Vascular Inc
NASDAQ:LMAT
|
1.7B USD | 49.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182.6B USD | 32.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
134.9B USD | 67.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.4B USD | 37.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.4B USD | 25.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.9B USD | 60.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.5B USD | 55.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 38.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.2B USD | 36.2 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
366B CNY | 32.2 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.5B USD | 78.9 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
44.3
2-Years Forward
P/E
39.7
3-Years Forward
P/E
36.5
You don't have any saved screeners yet
